374 related articles for article (PubMed ID: 31406672)
21. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Katopodi T; Petanidis S; Tsavlis D; Anestakis D; Charalampidis C; Chatziprodromidou I; Eskitzis P; Zarogoulidis P; Kosmidis C; Matthaios D; Porpodis K
Front Oncol; 2022; 12():1042125. PubMed ID: 36338748
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
23. Targeting of Nanotherapeutics to Infection Sites for Antimicrobial Therapy.
Dong X; Zhang CY; Jin G; Wang Z
Adv Ther (Weinh); 2019 Nov; 2(11):. PubMed ID: 33313384
[TBL] [Abstract][Full Text] [Related]
24. Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy.
Zhang Y; Long Y; Wan J; Liu S; Shi A; Li D; Yu S; Li X; Wen J; Deng J; Ma Y; Li N
J Drug Target; 2023 Mar; 31(3):229-242. PubMed ID: 35587560
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
[TBL] [Abstract][Full Text] [Related]
26. Cell-membrane engineering strategies for clinic-guided design of nanomedicine.
Huang D; Wang X; Wang W; Li J; Zhang X; Xia B
Biomater Sci; 2024 May; 12(11):2865-2884. PubMed ID: 38686665
[TBL] [Abstract][Full Text] [Related]
27. Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.
Zhao X; Amevor FK; Xue X; Wang C; Cui Z; Dai S; Peng C; Li Y
J Nanobiotechnology; 2023 Apr; 21(1):121. PubMed ID: 37029392
[TBL] [Abstract][Full Text] [Related]
28. Cell membrane-engineered nanoparticles for cancer therapy.
Liu W; Huang Y
J Mater Chem B; 2022 Sep; 10(37):7161-7172. PubMed ID: 35662316
[TBL] [Abstract][Full Text] [Related]
29. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
30. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
31. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
32. Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications.
Fan M; Jiang M
J Drug Target; 2020 Nov; 28(9):873-881. PubMed ID: 32298153
[TBL] [Abstract][Full Text] [Related]
33. Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases.
Su Y; Gao J; Kaur P; Wang Z
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33348630
[TBL] [Abstract][Full Text] [Related]
34. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics.
Song W; Jia P; Ren Y; Xue J; Zhou B; Xu X; Shan Y; Deng J; Zhou Q
Bioact Mater; 2023 May; 23():80-100. PubMed ID: 36406250
[TBL] [Abstract][Full Text] [Related]
35. Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics.
Pan L; Liu J; Shi J
Chem Soc Rev; 2018 Sep; 47(18):6930-6946. PubMed ID: 30062349
[TBL] [Abstract][Full Text] [Related]
36. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
Li B; Wang F; Gui L; He Q; Yao Y; Chen H
Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
38. Biomimetic approaches for targeting tumor-promoting inflammation.
Parodi A; Kostyushev D; Brezgin S; Kostyusheva A; Borodina T; Akasov R; Frolova A; Chulanov V; Zamyatnin AA
Semin Cancer Biol; 2022 Nov; 86(Pt 2):555-567. PubMed ID: 35472397
[TBL] [Abstract][Full Text] [Related]
39. Membrane-camouflaged biomimetic nanoparticles as potential immunomodulatory solutions for sepsis: An overview.
Wang Y; Liu L; Zheng X; Liu X
Front Bioeng Biotechnol; 2023; 11():1111963. PubMed ID: 36970623
[TBL] [Abstract][Full Text] [Related]
40. Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
Zhang H; Dong S; Li Z; Feng X; Xu W; Tulinao CMS; Jiang Y; Ding J
Asian J Pharm Sci; 2020 Jul; 15(4):397-415. PubMed ID: 32952666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
